| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 20.370 | 17.466 | 13.500 | 15.386 | 16.171 | 20.287 | 16.998 | 16.902 | 19.875 | 31.021 |
| Total Income - EUR | 20.370 | 17.470 | 13.624 | 15.389 | 16.176 | 20.291 | 17.001 | 16.905 | 19.877 | 31.024 |
| Total Expenses - EUR | 19.740 | 11.618 | 12.932 | 12.163 | 9.239 | 7.019 | 7.101 | 8.301 | 14.114 | 20.127 |
| Gross Profit/Loss - EUR | 630 | 5.853 | 692 | 3.226 | 6.937 | 13.272 | 9.901 | 8.605 | 5.763 | 10.897 |
| Net Profit/Loss - EUR | 19 | 5.455 | 555 | 2.840 | 6.452 | 12.702 | 9.407 | 8.337 | 5.594 | 9.415 |
| Employees | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Ex Prodmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 644 | 277 | 0 | 0 | 580 | 362 | 152 | 0 | 0 | 0 |
| Current Assets | 18.630 | 19.871 | 14.513 | 15.536 | 15.662 | 15.120 | 18.990 | 13.783 | 13.183 | 20.744 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 8.966 | 9.984 | 10.384 | 10.651 | 9.629 | 10.011 | 9.740 | 9.525 | 8.854 | 11.609 |
| Cash | 9.664 | 9.888 | 4.129 | 4.885 | 6.033 | 5.109 | 9.251 | 4.257 | 4.329 | 9.135 |
| Shareholders Funds | 18.590 | 17.438 | 2.374 | 2.948 | 6.557 | 12.805 | 17.885 | 9.200 | 9.713 | 19.073 |
| Social Capital | 45 | 45 | 44 | 47 | 46 | 45 | 44 | 45 | 44 | 44 |
| Debts | 684 | 2.710 | 12.139 | 12.588 | 9.684 | 2.677 | 1.257 | 4.582 | 3.471 | 1.671 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7490 - 7490" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Ex Prodmed Srl